OTC · ELVAY
Evolva Holding S.A.
Healthcare · Biotechnology
$1.16
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 8:26 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.24K
- P/E ratio
- -6.45
- Dividend yield
- 0.00%
- 52-week range
- $207.75 – $290.00
- Volume
- 0.4
- Avg. volume
- 1
Price performance
ELVAY price history
1M range · 0 trading sessions · Daily adjusted prices
ELVAY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ELVAY news
The latest Smart Investors Daily articles mentioning ELVAY.
Stock researchCompany · Overview
ELVAY research
Overview
Company profile and research snapshot.
Company profile
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
